Media Center

Dubai Health announced a strategic partnership between Al Jalila Children’s Hospital and the Children’s National Hospital in Washington, D.C., aiming to bring about a significant shift in pediatric healthcare.

The announcement follows a series of mutual visits. In the latest such visit, Dr. Amer Sharif, CEO of Dubai Health, led a delegation to the headquarters of Children’s National Hospital. The visit included a tour of the Sheikh Zayed Institute for Pediatric Surgical Innovation and the Children’s National Research Institute, during which both sides discussed ways to further strengthen their strategic collaboration.

Partnership of 8 years

For over eight years, the partnership has focused on technology, specialized pediatric training, and improving healthcare quality for children. The expanded collaboration will now include several key areas, such as advanced systems development, data management, and increased access to pediatric care through innovations such as remote patient monitoring. Additionally, comprehensive and specialized training programs will be launched for healthcare professionals at Al Jalila Children’s Hospital. Starting next year, a cohort of medical professionals will receive advanced training, integrating best practices and innovative care models from Children’s National Hospital to further elevate pediatric care standards.

“Together, we are deepening our shared commitment to advancing pediatric healthcare,” said Michelle Riley-Brown, President and CEO of Children's National Hospital. “This collaboration is about more than just exchanging knowledge – it's about building sustainable, innovative solutions that will improve health outcomes for children, both in the UAE and globally. We want to ensure every child receives the highest quality of treatment, no matter where they live.”

Leadership’s support highlighted

Dr. Amer Sharif, CEO of Dubai Health, said: “We are honored to visit the Children’s National Hospital in Washington, D.C. and the Sheikh Zayed Institute for Pediatric Surgical Innovation, affiliated with the hospital, where the support of our wise leadership in fostering innovation and scientific research is evident both locally and internationally. I extend my deepest gratitude to the government of the UAE for providing us the opportunity to strengthen ties with the most prestigious health and scientific institutions in the world. This has opened new avenues for collaboration and created new opportunities for effective, impactful partnerships.

“Strengthening our partnership with Children’s National Hospital, one of the world’s leading pediatric institutions, underscores our commitment to advancing children’s health through our integrated academic health system. The collaboration aligns with the Dubai Social Agenda 33 and is aimed at building an efficient healthcare ecosystem that meets the highest global standards. It also reinforces Dubai’s position as a global leader in healthcare, medical education, and scientific research.

“We extend our gratitude to Children’s National Hospital for their invaluable collaboration in strengthening this partnership. Through this alliance, we aim to enhance children’s care with an evidence-based approach, aligning with Dubai Health’s core value of putting the patient first throughout the healthcare journey,” he added.

Dr. Mohammed Al Awadhi, Deputy CEO of Al Jalila Children’s Hospital and Latifa Hospital, added: “The strengthening of our partnership with Children’s National Hospital will continue our work to elevate the standard of care for children in Dubai and beyond. Specifically, it will enable us to enhance operational efficiency, particularly in pediatric subspecialties, ensuring the best possible care for every child.

“We will also work closely with the Children’s National Hospital on leadership training, quality improvement, intensive care practices, and other areas to enhance the efficiency of pediatric care at Al Jalila Children’s Hospital.”

In 2018, Al Jalila Children’s Hospital signed a health information technology (IT) agreement with Children's National Hospital. Leveraging its extensive expertise and resources, Children’s National Hospital served as a strategic advisor, helping Al Jalila Children’s Hospital expand its health IT capabilities to deliver the highest quality of care for children. Building on this collaboration, another agreement in 2022 focused on education and consulting services, resulting in Children’s National Hospital conducting specialized training for cardiac ICU nurses, significantly enhancing Al Jalila Children’s Hospital’s clinical capabilities.

Dubai Health showcased its latest advancements in healthcare technology and innovation at GITEX, the biggest tech and startup show in the world. This year’s event theme centers on the integration of artificial intelligence (AI) across various sectors, with a particular focus on AI in health.

Teaming up with the Dubai Digital pavilion, Dubai Health is offering visitors a 20-minute journey that showcases how the integrated academic health system’s latest technological solutions are enhancing patient care and operational efficiency.

One of the key highlights of Dubai Health’s exhibit is the use of virtual reality (VR) technology at its Thalassemia Center, a solution currently being studied by Dubai Health’s Innovation and Digital Health team. This study aims to alleviate anxiety and pain during cannulation procedures. Patients wear VR headsets, immersing them in a therapeutic 3D environment designed to enhance comfort and overall experience during the procedure. This innovative, first-of-its-kind approach has the potential to transform the experience for patients, aligning with Dubai Health’s objective to elevate the standard of care and its vision to advance health for humanity.

In addition, Dubai Health’s Innovation and Digital Health team is also conducting a validation study on wearable ambulatory blood pressure monitoring technology using a smartwatch. The study evaluates the accuracy and effectiveness of this technology in delivering continuous blood pressure measurements, presenting a more convenient alternative to traditional methods. These initiatives underscore Dubai Health's ongoing efforts to incorporate advanced technology into healthcare to improve patient outcomes and streamline healthcare delivery.

Another project on display is the Ambient Clinical Documentation Solution, a tool designed to enhance clinical documentation efficiency by leveraging Generative AI. This solution enables clinicians to verbally document patient encounters, significantly reducing the time required for documentation. This allows clinicians to spend more time and provide better experience to our patients. The voice notes are processed by an AI-driven system that generates specialty-specific clinical notes, which clinicians then review and sign.

Atif Al Braiki, Chief Digital and AI Officer at Dubai Health,  commented, “Our participation in GITEX 2024 underscores our commitment to leveraging cutting-edge technology to transform healthcare delivery. By integrating AI and other advanced technologies in our day-to-day care, we are proud to be showcasing how we are constantly adapting to enhance patient outcomes, streamline operations, and set new standards in healthcare innovation. In line with our commitment to healthcare excellence, integrating these technologies will help us to realize our vision of advancing health for humanity.”

Dubai Health’s presence at GITEX 2024, being held at the Dubai World Centre, is a testament to its dedication to remaining at the forefront of the technological healthcare revolution, harnessing innovations to put the patient first.

Al Jalila Foundation, Emarat Al Youm newspaper, and the Islamic Affairs and Charitable Activities (IACAD) Department in Dubai, have signed a memorandum of understanding (MoU) to launch Your Donation Saves Lives, the second edition of an initiative to support patients in need of kidney transplantation in Dubai. The fundraising campaign urges businesses, entrepreneurs, and community members to embrace the initiative and offer essential support to those in need.

The MoU was signed by Executive Director of the Charitable Sector, Mohamed Musabih

of the Islamic Affairs and Charitable Activities Department in Dubai; Dr. Amer Al Zarooni, Chief Executive Officer of  Al Jalila Foundation; and Saud Al Darbi, Head of the News and Publishing Centre at Dubai Media Incorporated (DMI). The signing took place in the presence of Dr. Amer Sharif, Chief Executive Officer of Dubai Health.

Al Jalila Foundation, which leads Dubai Health's giving mission, will be responsible for identifying patients within Dubai Health’s healthcare facilities, including Dubai Hospital, Al Jalila Children’s Hospital, and Mediclinic City Hospital. Al Jalila Foundation will provide the healthcare facilities with comprehensive details about the patients, their medical conditions, and the funds required for transplants and post-operative care. Furthermore, they will take measures to ensure that these cases receive timely support from the initiative.

As a strategic partner, Emarat Al Youm newspaper will be responsible for transferring donations and contributions received through a hotline service. IACAD has pledged to collaborate with all parties and distribute donations to Dubai Health patients, identified by Al Jalila Foundation.

His Excellency Ahmed Darwish Al Muhairi, Director General of the Islamic Affairs and Charitable Activities Department in Dubai, confirmed that signing the MoU with Al Jalila Foundation and Emarat Al Youm newspaper supports the national agenda for achieving a better life for citizens and residents of the UAE, helping to empower and further humanitarian work in line with the vision of the wise leadership for supporting the spirit of giving in humanitarian work locally, regionally, and internationally. He explained that it also encourages community members to save lives and improve the quality of life of patients with organ failure, helping them return to being productive members of society.

Dr. Amer Sharif, Chief Executive Officer of Dubai Health, said, “We are grateful to our partners in this campaign, as it marks another significant step towards providing support to patients in need. Through this collaboration, we combine expertise and resources to positively impact individuals and society, advancing health for humanity. At Dubai Health, we’re guided by our primary value of ‘Patient First,’ and are dedicated to providing our communities the highest quality healthcare and treatment.”

Dr. Amer Al Zarooni, Chief Executive Officer of Al Jalila Foundation, said, “We at the Al Jalila Foundation are pleased to launch the second edition of the ‘Your Donation Saves Lives’ campaign, aimed at raising funds for kidney transplant operations. By providing critical support for life-saving surgeries and therapeutic services, we are building on the success of the campaign’s first edition, which treated over 38 kidney failure patients and significantly reduced the financial burden on their families. This ongoing collaboration is a testament to our commitment to advancing humanitarian efforts, underscored by Dubai Health’s spirit of giving.

Saud Al Darbi, Head of the News and Publishing Centre at Dubai Media Incorporated, said that Emarat Al Youm has a history of participating in important initiatives such as Your Donations Save Lives, so deciding to participate was natural. These include a strong legacy of partnerships with governmental and semi-governmental entities to deliver community initiatives.“Based on prior experiences, the newspaper has confidence that philanthropic businessmen and community members will react to the initiative so that these patients can be treated.”

Dubai Islamic Bank (DIB), the largest Islamic bank in the UAE, is making a substantial contribution to healthcare in Dubai with an AED 15 million contribution to Al Jalila Foundation, which leads the Giving mission of Dubai Health. The investment will support the development of Dubai Health’s Hamdan Bin Rashid Cancer Hospital, the first integrated and comprehensive cancer care hospital in Dubai, underscoring their commitment to the community’s well-being and advancing healthcare infrastructure.

DIB's contribution enables Dubai Health to launch an integrated model of cancer care at Hamdan Bin Rashid Cancer Hospital. Scheduled to open in 2026, the comprehensive care hospital will provide primary care services alongside advanced cancer treatment. This innovative approach will enable earlier detection and intervention, which is proven to optimize outcomes for patients in their cancer journey. The hospital will house multidisciplinary teams, including specialized cancer nurses, offering a full spectrum of services in one location – from diagnosis to treatment to supportive care. Select treatments and services will be made available to patients in the comfort of their homes.

DIB's support for the Hamdan Bin Rashid Cancer Hospital aligns with Dubai Health's mission to enhance patient outcomes through an integrated model of care. By conducting on-site research and clinical trials, the hospital aims to continuously improve patient outcomes by discovering new treatments and therapies founded in evidence-based medicine. Dubai Health’s mission to connect patient care, research, medical education, and giving at Hamdan Bin Rashid Cancer Hospital will set a new standard for excellence in cancer care.

Nawaf Al Rayssi, Head of Community Support Services at Dubai  Islmic Bank, said: “We are proud to partner with Al Jalila Foundation to empower Dubai Health on this transformative project. DIB’s responsible investment in the Hamdan Bin Rashid Cancer Hospital is a testament to our unwavering commitment to the health and well-being of our community. This world-class facility will undoubtedly set a new benchmark for cancer care in the region and beyond, providing hope and advanced treatment options for countless individuals. As a responsible financial institution, Dubai Islamic Bank remains committed to the transformational journey of this nation, shaping the future of the healthcare not only in the UAE, but the entire region.”

Dr. Amer Al Zarooni, CEO of Al Jalila Foundation, expressed his gratitude for DIB’s significant contribution. “Dubai Islamic Bank's generous contribution to the Hamdan Bin Rashid Cancer Hospital is a true testament to the power of community partnerships. This contribution to Al Jalila Foundation empowers Dubai Health to transform cancer care, putting patient care at the forefront of everything we do.  Together, we are one step closer to realizing this transformative, integrated healthcare facility, ultimately improving the health and well-being of our entire community.”

Dubai Health launched the Dubai Health Leadership Academy, a unique transformative initiative dedicated to creating a sustainable pipeline of leadership talent in healthcare. The Academy aims to foster a collaborative culture of leadership at all levels in Dubai’s academic health system and promote efficient operations to deliver its ultimate goal of ensuring a high standard of care for patients and their families.

The Dubai Health Leadership Academy launch event, held at the Etihad Museum, was attended by a distinguished gathering of delegates and healthcare professionals, including His Excellency Awadh Seghayer Al Ketbi, Director General of Dubai Health Authority; His Excellency Abdullah Ali bin Zayed Al-Falasi, Director General of the Dubai Government Human Resources Department; Her Excellency Aisha Abdulla Miran, Director General of Knowledge and Human Development Authority (KHDA); Adel Ahmad Al Redha, Deputy President and Chief Operations Officer of Emirates Airline; and Walid Saeed Al Awadhi, Board Member of Dubai Health.

Dubai Health Leadership Academy

The Academy reflects Dubai Health’s firm belief that investing in the professional growth of its staff is not only beneficial for individuals but also crucial for the overall strength of the organisation. This commitment to lifelong learning is one of four missions that form part of the academic health system’s innovative approach to elevate the standard of care and advance health for humanity.

Dr. Amer Sharif, CEO of Dubai Health and President of Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), commented on the importance of the Academy within Dubai’s first integrated academic health system: "The launch of the Dubai Health Leadership Academy reflects the vision and directives of the Dubai Health Board, led by His Highness Sheikh Ahmed bin Saeed Al Maktoum, and supported by His Highness Sheikh Mansoor bin Mohammed bin Rashid Al Maktoum, Vice Chairman of the Board. This initiative is designed to cultivate a sustainable and adaptable leadership framework in healthcare, equipping it to tackle future challenges, while empowering national talents to assume impactful leadership roles."

“At Dubai Health, we recognize that the strength of our healthcare system lies in the capabilities of our people. We are thrilled to announce the launch of our Leadership Academy, a groundbreaking initiative dedicated to nurturing the next generation of leaders in healthcare. At a time when our industry faces unprecedented challenges and opportunities, this academy represents our commitment to advancing both the quality of care and the caliber of leadership. As part of launching this academy, we are introducing its inaugural program, the Systems Leadership Program, in collaboration with Saïd Business School at the University of Oxford. We are delighted to partner with Oxford Saïd, whose renowned expertise in leadership development is helping us advance health for humanity.”

The Systems Leadership Program, co-designed with Saïd Business School

In a significant step towards advancing healthcare leadership, Dubai Health signed an agreement with Oxford Saïd in April 2023 to launch the Systems Leadership Program (SLP), the Academy's inaugural program. Co-designed with Oxford Saïd, the SLP will equip participants with the knowledge, skills, and attitudes necessary to navigate complexity, foster innovation, and cultivate a culture of excellence and safety within Dubai Health.

Dr. Eleanor Murray, Academic Director and Senior Fellow in Management Practice at Oxford Saïd, emphasized the importance of the partnership between Dubai Health and Oxford Saïd in the creation of the SLP, stating: “As we inaugurate the Systems Leadership Program, we hope to create a cadre of leaders with the knowledge, skills and attitude to transform healthcare delivery for the benefit of patients and serve the mission of the integrated academic health system.”

Professor Alawi Alsheikh-Ali, Deputy CEO and Chief Academic Officer of Dubai Health and Provost of MBRU, highlighted the significance of the Systems Leadership Program, saying: “At Dubai Health, our mission to integrate Care, Learning, Discovery and Giving, aims to create an engine for innovation, connected for the patient and delivered through a culture of collaboration across our integrated academic health system. Grounded in our values, I believe that the Systems Leadership Program will create greater alignment across our four missions and be pivotal in uniting us as one in the advancement of health to new heights of patient centric excellence.

We are deeply appreciative of Oxford Saïd, for their invaluable partnership in bringing this vision to life. Their expertise has been instrumental in ensuring that our leaders receive a world-class learning experience tailored to the unique needs of our academic health system.”

The inaugural Systems Leadership Program is an intensive 14-month initiative focused on generative leadership and systemic change that aims to equip Dubai Health’s leaders with the skills to drive innovation, foster a culture of accountability, and lead transformative projects. Engaging 200 participants across five cohorts of 40, the program is delivered primarily through in-person sessions and includes four comprehensive modules covering strategic leadership, healthcare innovation, patient safety, and building a high-performance culture. Participants will receive personalized coaching sessions from seasoned executive coaches, alongside insights from leading experts at Oxford Saïd, ensuring both global perspectives and tailored guidance for Dubai’s healthcare needs.

Dr. Mark O’Brien, Program Director of the SLP and Associate Fellow at Oxford Saïd, remarked: “The entire team at Oxford Saïd is excited by the comprehensive leadership curriculum that will be delivered by our leading faculty members and expert global practitioners. We are committed to providing an exceptional learning experience for all participants—one that will equip and inspire them to lead excellence in healthcare delivery within Dubai Health for many decades to come.”

Dubai Health continues to build on its "Patients First" promise with the launch of Blue Café, an initiative to improve autism care for children. Leveraging the expertise and resources within Dubai Health, the platform offers learning resources and funds research initiatives dedicated to improving autism care. Designed to be a ‘living lab’ within the community, the Blue Café is also an interactive space and supportive environment where parents and caregivers can connect, share experiences, and learn from each other.

Introduced initially as a parent support program at Al Jalila Children’s Hospital, it is understood that a recent diagnosis can be overwhelming for families, often leaving them feeling uncertain and isolated. Now, under Dubai Health, the initiative aims to elevate autism care for children through active participation in the community and harnessing the inherent benefits of the academic health system. Learning experts within Dubai Health have developed concise, research-informed content on a wide range of autism care topics, delivered in a user-friendly microlearning format. These bite-sized pieces of knowledge make it easy for families to fit learning into their busy schedules. The website will also host webinars, translating the latest research insights on autism into practical care strategies for families. Beyond information, the platform also provides a safe and supportive online community forum – a virtual space for families to connect, ask questions, and share valuable insights with one another.

Connecting families, Sharing Knowledge, Transforming Care

Looking ahead, Blue Cafe is brewing something special. In the coming months, a physical café in Dubai will open its doors, offering a welcoming space for families and caregivers to gather. All proceeds from this cafe will directly fund research initiatives dedicated to improving autism care.

Speaking on the initiative, Professor Nabil Zary, Senior Director of the Institute of Learning (IOL) at Dubai Health, said, “Blue Cafe was born from a desire to support the well-being of children with autism. We are proud to launch this first-of-its-kind living lab, combining the power of research with real-world experiences from the community. Thanks to generous donor support, we can establish a physical cafe, ensuring the project's financial sustainability and continued impact.”

Visit the Blue Cafe website to explore the online learning resources and join the Blue Café community forum.

Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) proudly celebrated its students’ successful participation in the international ‘Design for Change’ bootcamp organized by Queensland University of Technology (QUT), Australia. Held in Malaysia and Singapore, this event brought together students from diverse disciplines, including engineering, medicine, and design, to collaboratively develop innovative and sustainable solutions to global healthcare challenges.

MBRU’s inaugural participation was marked by significant achievements, with two students earning awards for Best Pitch and Best Strategy. These accolades underscore the exceptional talent nurtured at MBRU and highlight the university’s commitment to fostering innovation in healthcare.

Dr Yacine Hadjiat, leading Innovation in Health Science and Digital Health at Dubai Health and Associate Professor at the College of Medicine at MBRU shared, “The international bootcamp provided an unparalleled opportunity for our talented MBRU students to experience global diversity in healthcare. At Dubai Health, we see the immense value of providing such opportunities to our students, as we believe that healthcare is a global and collaborative sector that greatly benefits from multidisciplinary innovation. Our participation reinforces Dubai Health’s commitment to elevating healthcare standards by exploring new technologies and approaches that put the planet and our patients first."

More than 100 students from nine universities across Australia, Singapore, Malaysia, Thailand, Taiwan and the UAE, were challenged to address critical issues in sustainability and healthcare. The students showcased their creativity and problem-solving skills by developing and pitching their own projects. They also had the opportunity to visit various healthcare facilities, learn from experts, and actively collaborate with peers.

Maryam Alabdullah, a medical student at MBRU said, "The Design for Change bootcamp opened my eyes to the possibilities of innovation and collaboration in healthcare. I learned a lot from the different speakers, mentors, and peers who shared their insights and experiences with us. One of the highlights was visiting Taylor's University in Malaysia, where we learned how they use virtual reality.”

The Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) and the Mohammed Bin Rashid Space Centre (MBRSC) have initiated a landmark specialized training program in cell culture techniques for Emirati astronauts. This strategic initiative will equip astronauts to conduct groundbreaking research experiments, driving advancements in human health and equipping the nation’s space pioneers with the critical expertise needed for future missions.

Under the mentorship of leading experts at MBRU, three Emirati astronauts—Hazzaa AlMansoori, Astronauts Office Manager at MBRSC, Nora AlMatrooshi, and Mohammad AlMulla—successfully completed the intensive program. The rigorous training encompassed fundamental cell culture techniques, essential for biological research that involves maintaining and growing cells outside their original environment. Additionally, they underwent specialized glovebox training, a critical component that ensures safe and effective scientific experimentation in the unique environment of space.

The training program not only highlights the exceptional facilities and expertise available at MBRU but also marks a significant milestone in the UAE's journey to becoming a leader in space exploration and research. By equipping Emirati astronauts with these vital skills, the UAE is poised to make substantial contributions to the global scientific community, driving forward the frontiers of space and health research.

Over the course of the training, the astronauts engaged in lectures and hands-on practical sessions, covering the basics of mammalian cell culture, tissue culture laboratory setup, and the use of various laboratory equipment and reagents. The astronauts also practiced essential techniques such as pipetting, media preparation, cell viability assessment, cell counting, media changing, cell passing, and cell freezing and thawing. Additionally, they received specialized training on using the Glovebox and conducting independent practice under supervision, including troubleshooting and dealing with unexpected situations.

Professor Alawi Alsheikh-Ali, Deputy CEO and Chief Academic Officer of Dubai Health and Provost of MBRU, said, "Life sciences research in space is playing an ever-important role in advancing the future of patient care. This partnership with the MBRSC reflects the UAE's commitment to space exploration, and we are honored to be a part of it. We are proud to empower our Emirati astronauts with the necessary skills to conduct groundbreaking research, help accelerate scientific discovery, and also contribute to advancing health for humanity."

Adnan AlRais, Assistant Director General - Space Operations and Exploration Sector, MBRSC, said, “We are proud of our astronauts' achievements and remain committed to supporting their development as they pave the way for the next generation of space explorers. Our strategic partnerships with institutions like MBRU are crucial in ensuring that our astronauts are at the forefront of scientific research and technological advancements, ultimately contributing to the UAE's vision of becoming a leading nation in space exploration and research.”

Hazzaa AlMansoori, Astronauts Office Manager, MBRSC, said, “We trained on the process of stem cell transplantation and how to use laboratory tools in space, which will serve us in future space missions to the Moon and Mars. Our collaboration with MBRU is a crucial step in ensuring we are equipped with the knowledge and skills needed to excel in our roles as astronauts and ambassadors of the UAE’s growing presence in space exploration."

Astronaut Nora AlMatrooshi, describing the hands-on experiences in the laboratory, said, “We delved into the intricate process of thawing and freezing cells, gaining practical skills in handling them using various laboratory equipment. This training has allowed us to further develop our scientific skills and understanding.”

Astronaut Mohammad AlMulla said: “Our training was composed of several distinct stages. We began by learning about different types and classifications of cells, including their growth patterns and preservation methods. Furthermore, we received hands-on training in cell division and storage, preparing us for future missions.”

Dr. Mohamed Jamal, Stem Cell Researcher and Lead for the MRAT Program at MBRU said, “We were honored to collaborate with MBRSC and contribute to the UAE’s space ambitions during the thorough the program. Building on our current collaboration we have developed a program to equip the astronauts with the essential skills and knowledge to perform cutting-edge research in the field of stem cells and molecular biology. The astronauts demonstrated remarkable dedication and enthusiasm throughout the training. We hope that this program will inspire more young Emiratis to pursue careers in STEM fields and join the national efforts to advance space discovery and scientific innovation.”

The program builds on MBRU’s growing legacy of supporting space travel in the UAE, with Dr. Hanan Alsuwaidi, Dubai Health's Chief Business Officer, serving as flight surgeon for UAE astronauts H.E. Dr. Sultan Saif AlNeyadi and Hazzaa AlMansoori who conducted research projects from MBRU aboard the International Space Station (ISS).

His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, met with top graduates from the Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) Class of 2024.

His Highness commended the MBRU graduates for their dedication and perseverance in striving for excellence throughout their educational journey. He urged them to continue their commitment to excellence as they transition into their professional careers, noting that their achievements will inspire future generations of medical professionals. His Highness encouraged them to remain steadfast in their pursuit of knowledge, as their contributions will shape the future of healthcare and enhance the well-being of society.

Highlighting efforts to reinforce the UAE and Dubai's position as a center for excellence in medicine, health sciences, and scientific research, His Highness underscored the role of institutions like MBRU as well as healthcare professionals in the nation's progress. MBRU is a pioneering institution that significantly contributes to expanding scientific research and innovation, as well as empowering the next generation of national talent, he added.

The meeting was held in the presence of His Highness Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum, Crown Prince of Dubai, Deputy Prime Minister and Minister of Defence of the UAE, and Chairman of The Executive Council of Dubai.

Commenting on the occasion, His Highness Sheikh Ahmed bin Saeed Al Maktoum, Chancellor of MBRU and Chairman of the Board of Directors of Dubai Health, said: “I extend my deepest gratitude to His Highness Sheikh Mohammed bin Rashid Al Maktoum for his unwavering support. His visionary leadership in establishing Dubai Health and his dedication to advancing healthcare and education in Dubai have been instrumental in shaping the Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU). We take immense pride in our graduates who embody the values and aspirations of our nation. We are confident they will make significant contributions to the field of healthcare, both locally and on the global stage.”

Also present at the meeting were Her Excellency Dr. Raja Easa Al Gurg, Chairperson of the MBRU Council and Dubai Health Board Member; His Excellency Dr. Amer Sharif, President of MBRU and CEO of Dubai Health; and Professor Alawi Alsheikh-Ali, Provost of MBRU and, Deputy CEO and Chief Academic Officer of Dubai Health.

At the event, Her Excellency Dr. Raja Easa Al Gurg said: “We extend our sincerest thanks and profound gratitude to His Highness Sheikh Mohammed bin Rashid Al Maktoum for meeting our graduates and celebrating their remarkable achievements. This moment is a profound honor for our graduates. Inspired by a visionary leader whose foresight has shaped the trajectory of healthcare and education, our graduates now stand as inspiring role models for excellence across all fields.”

Addressing the gathering, His Excellency Dr. Amer Sharif shared: “The gathering highlights His Highness Sheikh Mohammed bin Rashid Al Maktoum’s commitment to fostering excellence and innovation in the field of medicine and health sciences. Under his vision, our integrated academic health system was established to empower all learners, from students to experienced clinicians, with a scholarly-driven ethos that not only advances the healthcare field but directly translates to better care for our patients at Dubai Health. We are immensely proud of the accomplishments of our graduates and alumni and remain dedicated to nurturing talent and developing the next generation of healthcare professionals.”

The 2024 graduating class from MBRU included 153 graduates from 24 programs, spanning the Hamdan Bin Mohammed College of Dental Medicine, the College of Medicine, the College of Nursing and Midwifery, and the Deanship of Graduate Medical Education. Nearly 40% of the graduates were young Emiratis, with the remaining graduates representing 27 different nationalities. The diversity of the graduating class highlights MBRU’s commitment to advancing healthcare on a local and global scale.

The Mohammed Bin Rashid Space Centre (MBRSC) announced the signing of an agreement with Dubai Health to cooperate in the provision of an optimum environment to ensure the health and safety of astronauts, in addition to enhancing innovation in health sciences. The agreement was signed by H.E. Salem Humaid AlMarri, Director General, MBRSC, and H.E. Dr. Amer Sharif, CEO, Dubai Health, at the Centre’s headquarters recently.

H.E. Salem Humaid AlMarri, Director General, MBRSC, said, “The health and safety of our astronauts are paramount, and this agreement will ensure that they receive the best possible care before, during, and after their missions. In the rapidly evolving space sector, collaboration is the way forward. By integrating our efforts with Dubai Health, we are not only enhancing the well-being of our astronauts but also pushing the boundaries of space healthcare and driving innovation in health sciences. This partnership not only strengthens our capabilities but also underscores the UAE’s commitment to pioneering advancements in space and health technologies.”

H.E. Dr. Amer Sharif, CEO, Dubai Health, said, “Emirati astronauts are a source of national pride and a significant asset for the UAE in advancing knowledge, scientific capabilities, as well as raising our great country's profile on a global stage. At Dubai Health, we are proud to play a direct role in ensuring the health and safety of our astronauts by offering an environment for quality healthcare, providing comprehensive health assessments and supporting the monitoring of health during space missions.”

He further commented, “This agreement aligns with our strategic objectives, encompassing key pillars of care, learning and discovery to elevate the standard of care and to advance health for humanity, whilst helping to strengthen our nation’s healthcare and space capabilities.”

The agreement outlines a range of initiatives by MBRSC to ensure the health and well-being of astronauts. In cooperation with Dubai Health, the Centre will conduct comprehensive health assessments for astronauts prior to mission deployment, including medical examinations, screenings, and evaluations to ensure fitness for space travel.

Furthermore, MBRSC will provide astronaut training programs in collaboration with Dubai Health, ensuring that astronauts are adequately prepared for health-related protocols and emergencies, in addition to integration and exchange of health data with healthcare providers for comprehensive astronaut care. Both entities will also work together to enhance medical technologies and methodologies related to space healthcare, fostering continuous improvement.

Dubai Chambers announced that it has signed a Memorandum of Understanding (MoU) with Al Jalila Foundation, donating AED15 million to support the Hamdan Bin Rashid Cancer Hospital, the first fully integrated and comprehensive cancer hospital in Dubai.

Dubai Chambers’ donation to the Hamdan Bin Rashid Cancer Hospital exemplifies their unwavering commitment to enhancing community welfare and supporting critical initiatives that improve quality of life.

The MoU was signed by His Excellency Abdul Aziz Abdulla Al Ghurair, Chairman of Dubai Chambers, and Her Excellency Dr. Raja Easa Al Gurg, Chairperson of Al Jalila Foundation Board of Directors and Dubai Health Board Member, at the Dubai Chambers’ headquarters.

His Excellency Abdul Aziz Abdulla Al Ghurair said: “In line with the vision of His Highness Sheikh Mohammed Bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, to strengthen social responsibility, Dubai Chambers is keen to support national projects that contribute to improving the quality of life and enhancing community services, thereby fostering social and economic development.”

Al Ghurair added: “Our cooperation with Al Jalila Foundation to support the Hamdan Bin Rashid Cancer Hospital reflects our commitment to the principles of social responsibility and the importance of charitable and humanitarian work, as part of our ongoing efforts to effectively contribute to serving the community.”

Expressing her gratitude for the donation, Her Excellency Dr. Raja Al Gurg said: “We are grateful to Dubai Chambers for their generous contribution toward establishing Dubai’s first comprehensive cancer hospital. Through this collaboration and the power of giving, Al Jalila Foundation is paving the way for enhanced care for cancer patients and their families in Dubai. This partnership aligns perfectly with our mission to foster a healthy and sustainable society, enhancing health and wellbeing through humanitarian, developmental, and community-focused efforts.”

Al Jalila Foundation is currently developing the Hamdan Bin Rashid Cancer Hospital, spanning 56,000 square meters. The hospital will feature 50 clinics, 30 clinical research areas, 60 infusion rooms, 10 urgent care rooms, five radiotherapy rooms, and 116 beds, complemented by 19 gardens spread across the campus. These gardens will offer patients space for recovery and opportunities to spend time outdoors with their families, promoting enhanced mental well-being.

The new facility will house a multidisciplinary team, including specialized nursing staff, and will provide integrated healthcare services from initial diagnosis through treatment, ensuring comprehensive care under one roof. Selected treatments and services will also be accessible to patients in their homes, ensuring continuity of affordable care and reflecting Dubai Health’s commitment to prioritizing patient needs.

DP World Foundation has donated Dh15 million to Al Jalila Foundation to support the development of the Hamdan bin Rashid Cancer Hospital, highlighting its commitment to corporate social responsibility and community welfare.
The contribution is part of DP World Foundation's broader efforts to support vital healthcare services and improve access to quality healthcare for cancer patients.
The allocated funds will support the development of Dubai's first integrated cancer hospital, scheduled to open in 2026. The advanced healthcare facility, which is being established in collaboration with the Al Jalila Foundation, will feature 50 clinics, 30 research areas, 60 infusion rooms, and 116 inpatient beds spread across a sprawling 56,000-square-metre campus.
His Excellency Nasser Abdulla Al Neyadi, Chief Officer Group Security, Government Relations & Public Affairs (GRPA), and DP World Foundation, presented the contribution during a visit to the Al Jalila Foundation, including the Mohammed Bin Rashid Biomedical Research Centre, where he met with key healthcare officials and stakeholders.
HE Al Neyadi said: "We are deeply committed to making a real difference in society, and this donation reflects our dedication to supporting healthcare institutions and ensuring that quality care is accessible to everyone. We are proud to contribute to such a respected institution leading the way in cancer care and research. Together, we aspire to foster a healthier future for all."
Dr. Amer Al Zarooni, CEO of the Al Jalila Foundation, said: "We extend heartfelt gratitude to the DP World Foundation for their generous donation towards the Hamdan Bin Rashid Cancer Hospital. The collaboration exemplifies the transformative impact of partnerships in accelerating the delivery of critical healthcare services and further emphasizes Dubai Health's commitment to improving the health and well-being of our community.
Together, with the support of our partners, we are steadfast in our dedication to transforming lives and ensuring better health for everyone."
The philanthropic arm of DP World, DP World Foundation, is committed to promoting social responsibility and supporting those in need, regardless of nationality, race, or religion. Earlier this year, DP World Foundation contributed Dh 10 million to the Mothers' Endowment Campaign launched to support the education of millions around the world.

His Highness Sheikh Ahmed bin Saeed Al Maktoum, Chancellor of the Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) and Chairman of the Board of Directors of Dubai Health attended the graduation ceremony of MBRU Class of 2024 on Tuesday, June 25 at the Dubai World Trade Centre.

Held under the patronage of His Highness Sheikh Ahmed bin Saeed, the graduation ceremony for the Class of 2024 honored 153 graduates from 24 programs offered by the Hamdan Bin Mohammed College of Dental Medicine, the College of Medicine, the College of Nursing and Midwifery, and the Deanship of Graduate Medical Education.

The 2024 graduating class consisted of nearly 40% young Emiratis and graduates from 27 different nationalities, highlighting MBRU's dedication to Dubai Health's broader vision of advancing health for humanity. This demonstrates MBRU's role as an emerging hub for aspiring healthcare professionals from both the UAE and around the globe.

His Highness Sheikh Ahmed bin Saeed said: As part of Dubai Health, the Mohammed Bin Rashid University of Medicine and Health Sciences continues to play a key role in fostering the next generation of innovative medical professionals in Dubai, who are equipped to enhance the quality of healthcare services in the city and adapt to future challenges. This mission aligns perfectly with the vision of His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, to establish Dubai as a global hub for healthcare and education.”

His Highness conveyed his heartfelt congratulations to the Class of 2024 for their achievements and extended his best wishes for their success as they embark on a journey to advance health for humanity

In her welcome address, Her Excellency Dr. Raja Easa Al Gurg, Chairperson of MBRU Council and Dubai Health Board Member, said: “We dedicate this honorable achievement to His Highness Sheikh Mohammed bin Rashid Al Maktoum, whose visionary leadership in enhancing healthcare for the people of the UAE serves as a profound inspiration and has laid the groundwork for our academic journey toward achieving the highest standards in advancing health for humanity.”

She added: “MBRU was founded under the directives of His Highness Sheikh Mohammed eight years ago, underscoring his unwavering commitment to the healthcare sector. His wisdom and generosity have led to the establishment of a globally connected university, founded on a vision to create an innovative, integrated healthcare education and research system that benefits the UAE and beyond.”

Addressing the gathering, His Excellency Khalfan Belhoul, Chief Executive Officer of the Dubai Future Foundation, emphasized the importance of courage as the graduates embark on their careers as doctors, nurses, and dentists. He highlighted that every interaction, diagnosis, and decision has the potential to significantly impact lives.

Belhoul also noted the critical role the graduates now play in a field that can transform lives, emphasizing that it is during times of uncertainty that their courage will be most essential.

Drawing from his experience at the Dubai Future Foundation, he acknowledged that uncertainty and the unknown are inherent to the concept of the future. While the future remains unpredictable, he stressed that together, and with the right tools, they can navigate and make the most of the unknown.

His Excellency Dr. Amer Sharif, President of MBRU and CEO of Dubai Health said, “It is with great pride that we celebrate the achievements of MBRU's graduating Class of 2024. These exceptional graduates are poised to assume leading roles and responsibilities, not only within the UAE but also on an international scale. As students studying within Dubai Health's integrated academic health system, we are proud that our core values have been instilled throughout their studies that will see them endeavor to always put the patient first in their forthcoming professional careers."

Dr. Meznah Ali Rasheed, the graduation commencement speaker and a future physician, said: “My colleagues and I have chosen to prioritize the well-being of others. Within the walls of hospitals, we have witnessed the fragility of life and the resilience of the human spirit. Above all, we have learned what it truly means to be a doctor. My fellow graduates, the world awaits us. We are ready. We are prepared. We are the future.”

MBRU, which leads the learning and discovery missions of Dubai Health, applies a scholarly-driven ethos aimed at advancing the healthcare field and improving patient care.

Building on Dubai Health's vision to advance health for humanity, The Royal Marsden NHS Foundation Trust has been selected to support the clinical and operational development of the Hamdan Bin Rashid Cancer Hospital (HBRCH), Dubai's first integrated, comprehensive cancer hospital.

The partnership marks a significant step forward in enhancing the standard of cancer treatment in Dubai, where specialized and compassionate care will be accessible in one place.

As one of the world's leading hospitals dedicated to cancer diagnosis, treatment, research, and education, The Royal Marsden will work with Dubai Health to establish a model of excellence in comprehensive cancer care at HBRCH. Their renowned expertise will be leveraged across several key areas, including developing specialist, evidence-based models of care, early diagnosis, and treatment pathways that guide patients through every step of their journey.

The HBRCH program of care will span from early detection to treatment, recovery, and post-treatment support. A key focus of this partnership will be building a world-class, specialized team of cancer care professionals. This will involve creating a robust workforce plan, developing advanced training programmers, and fostering a culture of continuous learning. Additionally, the partnership will seek to establish a cancer research program, fostering a culture of discovering transformative advancements in cancer care.

Her Excellency Dr. Raja Easa Al Gurg, Chairperson of Al Jalila Foundation Board of Directors and Member of Dubai Health Board of Directors, said, “We are honored to join forces with The Royal Marsden, a global leader in cancer research and treatment. Their renowned expertise and approach to care perfectly complement the care, learning, discovery, and giving missions of our integrated academic health system. Through this partnership, we are honoring the collective generosity of our esteemed donors whose unwavering support to Al Jalila Foundation is fulfilling our vision for the Hamdan Bin Rashid Cancer Hospital to become a beacon of hope for patients and families facing a cancer diagnosis. It propels us closer to achieving the Dubai Social Agenda 33 goal of delivering a world-class healthcare system of the highest efficiency and quality."

Dame Cally Palmer, Chief Executive, The Royal Marsden, said: “I am delighted that The Royal Marsden has been chosen to work in partnership with Dubai Health to advance the clinical development of the Hamdan Bin Rashid Cancer Hospital. This is an excellent opportunity for international collaboration, and to adapt the best practices in state-of-the-art healthcare provision and establish the structure upon which this advanced, innovative and future-looking hospital can be based.”

“At The Royal Marsden our integrated NHS and Private Care model, underpinned by a research and academic infrastructure, delivers outstanding personalized care for our patients. Through a staged program of work, The Royal Marsden and Dubai Health aim to establish a long-term strategic partnership that will not only develop a new hospital but support specialized cancer care across the wider healthcare system in Dubai,” she added.

Set to open in 2026, the HBRCH will offer a groundbreaking model of care under Dubai Health. As part of Dubai’s first integrated academic health system, the comprehensive cancer hospital will create multidisciplinary teams to spearhead a transformative shift in care delivery. Research and clinical trials will be at the heart of the hospital, fostering a culture of discovery and accelerating progress in cancer care. With 50 clinics, 30 research areas, 60 infusion rooms, and 116 inpatient beds spread across a sprawling 56,000-square-metre campus, the hospital is positioned to become a beacon of hope for cancer patients in the UAE and the region.

Dubai Health, the first integrated academic health system in Dubai, has signed a strategic partnership agreement with the Erada Centre for Treatment and Rehab. The agreement aims to enhance collaboration between both organizations, focusing on an integrated information system, as well as medical, academic and research initiatives. The partnership specifically aims to develop an advanced model of care for patients with substance abuse disorders.

The agreement creates the framework for cooperation in a wide range of areas including patient transfer for additional medical requirements, logistical support, information exchange, training, and development. In addition, Erada will collaborate with the Mohammed Bin Rashid University of Medicine and Health Sciences to develop educational programs related to substance abuse treatment, residency, and research.

His Excellency Dr. Amer Sharif, CEO of Dubai Health, stated: “The strategic partnership with the Erada Centre for Treatment and Rehab in Dubai is part of Dubai Health’s constant efforts to further develop the healthcare system in Dubai. It reflects our commitment to enhancing medical care and rehabilitation services, guided by our four missions: Care, Learning, Discovery and Giving. Through these missions, we aim to deliver world-class healthcare services and implement international best practices, positioning Dubai as a leading global model for advancing health for humanity.”

“Apart from offering effective treatment and rehabilitation services, the Erada Centre for Treatment and Rehab in Dubai actively contributes to framing policies, strategies, and plans. It also plays a vital role in raising awareness about preventive measures, significantly contributing to the overall development of Dubai’s healthcare system. Through this strategic partnership, we aim to leverage the centre’s expertise and high-quality services to enhance the capabilities of our healthcare system, in line with our Patient First promise.”

His Excellency Abdulrazaq Amiri, CEO of the Erada Centre for Treatment and Rehab in Dubai, emphasized the Centre’s commitment to reinforcing cooperation with Dubai’s government departments to promote exchange of experiences and enhance the quality of services for both citizens and residents, particularly in the field of addiction treatment and rehabilitation. Amiri praised Dubai Health for its role as a leading health institution in the emirate, noting that its goals and vision are in line with those of the Erada Centre.

Amiri commended Dubai Health for its support in meeting the Centre’s needs for medical services that complement its addiction treatments. These include dental care, emergency case management referred by the Centre, as well as medical, pharmaceutical and laboratory services.

Furthermore, Dubai Health supports the Erada Centre’s initiatives to establish a comprehensive framework to enhance the effectiveness of treating patients with substance abuse disorder in Dubai and the rest of the country.

The partnership marks a significant milestone in strengthening the collaboration between Dubai Health and the Erada Centre for Treatment and Rehab, reflecting their shared commitment to advancing healthcare services and rehabilitation in Dubai.

Dubai Health, the first integrated academic health system in Dubai, has partnered with the Angelman Syndrome Foundation to establish the GCC’s first dedicated clinic at Al Jalila Children’s Hospital. This is the first-of-its-kind clinic in the region and aims to improve care for patients with Angelman Syndrome and raise awareness of this rare neurological disorder. The clinic will provide a supportive community hub where patients, families and caregivers can connect with experts and receive the best evidence-based care, bridging a gap in healthcare for those living with this condition.  

In line with Dubai Health’s Patient First promise, the partnership with the Angelman Syndrome Foundation represents new hope for individuals and families living with this rare neuro-genetic disorder. Affecting approximately one in 500,000 people worldwide, the early symptoms of Angelman Syndrome include a significant delay in obtaining developmental milestones such as walking within the first 12 months. Other clinical findings include speech delay, movement or balance disorder and often present with an apparent happy demeanor with frequent laughter and excitability.

The clinic will provide families in the UAE access to specialist healthcare professionals and evidence-based care while also enhancing future treatment through the power of Dubai Health’s integrated academic health system. Through harnessing the education and research that takes place within Dubai Health, this partnership aims to significantly improve the lives of patients and their families.

Dr. Abdulla Al Khayat, CEO of Al Jalila Children’s Hospital, said: “We are delighted to partner with The Angelman Syndrome Foundation to bring this specialized clinic to Al Jalila Children’s Hospital, part of Dubai Health care network. This crucial partnership is a beacon of hope for patients and families affected by this rare condition. By ensuring that we deliver the highest standard of care and driven by our Patient First promise, we hope to empower Angelman Syndrome patients and their families to lead fulfilling lives.”

Also commenting on the partnership, Amanda Moore, CEO of the Angelman Syndrome Foundation, said: "We are deeply honored to join forces with Dubai Health and Al Jalila Children's Hospital in this transformative initiative. This clinic will offer families in the UAE access to professionals with deep knowledge of Angelman Syndrome, expertise that has traditionally been challenging to locate. Raising awareness of rare conditions like Angelman Syndrome is crucial for early diagnosis and better patient outcomes. This initiative is part of our LADDER Learning Network, designed to bridge critical gaps in the healthcare landscape for families dealing with this rare disorder. We look forward to working closely with the team at Dubai Health to making a significant difference to the lives of patients and their families.”

Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), which leads the Learning and Discovery missions of Dubai Health, the first integrated academic health system in Dubai, joined forces with the United States Centers for Disease Control and Prevention (CDC) and National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH) to host the joint conference: Research and Public Health Priorities in the MENA Region: Lessons from the COVID-19 Pandemic and Future Preparedness.

Held at MBRU, the event brought together regional experts and stakeholders from the Middle East and North Africa (MENA), alongside counterparts from the U.S. and other regions to exchange insights and foster collaboration in addressing pressing public health challenges.

The U.S. CDC established the MENA Regional Office in Muscat, Oman in 2020 to strengthen public health collaborations in the region and enhance global health security. In addition to the CDC personnel in Muscat, CDC will soon place a Regional Technical Advisor for Emerging Infections and Zoonotic Diseases in Abu Dhabi to support additional efforts in UAE and the region. This presence, along with the NIAID in the region, fosters scientific and public health collaborations with the U.S., and the MENA region, including sharing best practices and innovations, such as this conference.

The conference welcomed approximately 200 delegates, including academics, healthcare practitioners, and public health professionals from 16 countries, including an impressive lineup of nearly 40 speakers and chairs and 40 abstract presenters. Featuring sessions, panel discussions, and abstract presentations, conference topics ranged from reflections on the COVID-19 pandemic's impact and predictions for future outbreaks, to strategies for preparedness and response. The conference also afforded opportunities for networking and collaboration among the participants.

The conference also featured keynotes by notable figures, including Deputy Chief of Mission Eric Gaudiosi, of the U.S. Mission to the UAE; H.E. Dr. Amer Sharif, Chief Executive Officer of Dubai Health, and President of MBRU; H.E. Professor Alawi Alsheikh-Ali, Deputy CEO of MBRU; from the U.S. Centers for Disease Control and Prevention (CDC), Dr. Henry Walke, Director of the Office of Readiness and Response, Dr. Kayla Laserson, Director for the Global Health Center, Heather Burke, Regional Director, U.S. CDC Middle East/North Africa Regional Office in Muscat, Oman, ; and from NIAID, Dr. Daniel Douek, Senior Investigator and Chief of the Human Immunology Section at the Vaccine Research Center, and Dr. Mohamed H. Sayegh, Senior Scientific Advisor to the Director.

In his opening keynote address, H.E. Dr. Amer Sharif, Chief Executive Officer of Dubai Health and President of MBRU, highlighted Dubai's proactive response to the COVID-19 pandemic, drawing upon his role as Chair of the Dubai COVID-19 Command and Control Center. He emphasized the significance of collaboration and working together in a coordinated approach toward advancing healthcare solutions.

He said, “We are proud to host healthcare leaders from all around the region and the U.S. for the Research and Public Health Priorities in the MENA Region conference here in Dubai. A new frontier of opportunities has been created since the COVID-19 pandemic, and now, more than ever, we stand at the cusp of a transformative era, where not only do we reflect upon lessons learned but also to chart new territories in a conducive environment that nurtures collaboration across the entire region and beyond. As Dubai’s first integrated academic health system, we believe that through uniting efforts, we advance health and shape a brighter future for all.”

In his opening remarks, DCM Gaudiosi stated, “Supported by the U.S. COVID-19 response supplemental funding and facilitated by the support of the U.A.E government and the U.S. diplomatic missions in the region, our gathering today focuses on health security, preparedness, and response—a testament to our shared priorities and our collective will to invest in healthier futures.”

Indeed, many of the participants were on the front lines during the COVID-19 pandemic – from clinicians, incident managers, and leaders in local, national, and global response. It was evident the importance of partnership, sharing of accurate information, forecasting and analytics to inform decision making, and health communications in protecting health not just in emergencies, but also in mass migration events and outbreak response. The conference concluded with energized participants with new and strengthened relationships and ideas for collaboration to predict, prepare, and be ready to respond to the next health threat.

Dubai Health, the first integrated academic health system in the emirate, has announced the addition of a new cohort of Emirati nurses to its team. This expansion strengthens healthcare delivery across the system and reflects Dubai Health’s commitment to nurturing and promoting local talent within the healthcare sector.

The new cohort, all graduates holding a Bachelor of Science in Nursing from the College of Health Sciences at the University of Sharjah, has been strategically placed across four locations within Dubai Health: Al Jalila Children’s Hospital, Rashid Hospital, Hatta Hospital, and Latifa Hospital.

Commenting on the announcement, His Excellency Dr. Amer Sharif, Chief Executive Officer of Dubai Health, stated: “We are proud to continue to place local talent at the heart of the frontline workforce at Dubai Health. The latest cohort of Emirati nurses brings a wealth of knowledge and a local perspective to help our integrated academic health system elevate the standard of care and advance health for humanity. We look forward to their contribution to serving Dubai and its communities.”

Khalifa Baqer, Chief Operating Officer at Dubai Health said: “The arrival of these talented Emirati nurses marks another significant milestone for Dubai Health. Their dedication and passion for healthcare delivery will undoubtedly enhance our services and patient care. We are proud to offer a supportive environment for Emirati talent and are fully committed to supporting these nurses as they contribute to our vision to advance health for humanity.”

Nursing at Dubai Health thrives with 4,300 dedicated nurses committed to advancing health. Through mentorship and development programs, Dubai Health nurtures nursing leadership, empowering nurses to drive change in healthcare. The Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), which leads the Learning and Discovery missions, offers specialized master’s programs tailored to local healthcare demands. The Master of Science in Cardiovascular Nursing and the Master of Science in Pediatric Nursing equip nurses with skills for optimal patient care, shaping the future of nursing and elevating healthcare quality.

Dubai Health, the first integrated academic health system in Dubai, is embracing virtual reality (VR) technology to improve patient care across its hospitals and healthcare centers. This initiative kicks off with a study and implementation program at the Thalassemia Center, exploring the use of VR technology to reduce anxiety and pain during cannulation (needle insertion) procedures for thalassemia patients. This study, the first of its kind for this specific patient group in Dubai, holds promise for a more comfortable and positive healthcare experience.

Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), which leads the Learning and Discovery missions of Dubai Health, will conduct and document the study. Unlike prior studies that primarily relied on subjective experiences, this novel approach will incorporate objective measurements such as eye movement tracking and heart rate to assess the effectiveness of VR technology, marking a significant advancement in medical discovery.

Dr. Fatheya Abbas Al Khaja, Director of the Thalassemia Center, expressed her profound optimism for the initiative, stating, “The application of VR technology at the Thalassemia Center has the potential to transform the experience for patients undergoing cannulation procedures. Throughout my years at the Thalassemia Center, we have explored numerous modalities to alleviate the pain of our patients. This program epitomizes our Patient First promise to provide a more comfortable and anxiety-free experience, not just for the patients, but also for their families who witness this process. We are eagerly anticipating the results of this study.”

Separate from the MBRU study, the selected VR technology had been tested extensively. It demonstrated clinically effective results in 14 published and 30 ongoing studies, providing a solid foundation for its use in improving patient experiences.

This program marks the first phase of integrating VR technology across Dubai Health hospitals and healthcare centers, with plans to extend its application into medical procedures at Al Jalila Children's Hospital and Latifa Hospital. Beyond immediate application at the Thalassemia Center, the program also focuses on developing novel VR environments and experiences tailored to the local needs of patients in Dubai. The long-term vision is to develop future iterations of AI-powered VR technology to further personalize the patient experience, a collaborative effort engaging both MBRU students and our clinical staff.

“This program is the first of many to showcase how digital solutions can improve patient care within Dubai Health,” remarked Dr. Yacine Hadijat, Associate Professor of Innovation in Health Science and Digital Health at MBRU’s College of Medicine. “One of the inherent advantages of our integrated academic health system is the ability to cultivate a continuous cycle of improvement within our care, learning and discovery missions. By exploring digital innovations, such as VR technology, we are simultaneously training future healthcare professionals to champion patient-centered care and contribute toward the medical discovery of tech-enabled healthcare solutions. This multifaceted approach holds immense promise to transform the patient journey for countless individuals.”

By spearheading such initiatives, Dubai Health remains at the forefront of healthcare innovation, reaffirming its commitment to delivering patient-centered care and advancing the standard of medical excellence in the region.

Surgeons at Dubai Health have announced a groundbreaking achievement: the successful removal of the world's largest adrenal tumor at Dubai Hospital. Dubai Hospital's multidisciplinary approach to the surgery, which forms part of the emirate's first integrated academic health system, ensured the best possible outcome. The successful surgery also reflects Dubai Health's promise to put the Patient First. 

The 69-year-old patient, previously in good health, was referred to the hospital's emergency unit due to a massive abdominal mass discovered during a scan. Struggling with walking and breathing for months prior to surgery, the patient's condition necessitated immediate specialized care.

Specialists from various disciplines across Dubai Health gathered at Dubai Hospital to deduce the best course of action for the patient. The four-hour procedure was performed by a multidisciplinary team of experts from urology, oncology, radiology, interventional radiology, vascular surgery, general surgery, and anesthesia. Measuring 27 x 26 cm and weighing 9.4 kilograms, the tumor’s size and weight surpassed all previous records.

Dr. Fariborz Bagheri, Consultant Urologist at Dubai Hospital, who led the operation, highlighted the complexity and risks associated with the procedure. "Due to the tumor's size and its compression on vital structures, surgical intervention posed considerable challenges," stated Dr. Fariborz. "However, without intervention, the patient's survival was at high risk." 

Reflecting on the outcome, Dr. Fariborz expressed gratitude for the successful procedure, attributing it to the combined efforts of the medical and surgical teams. He further commented, "We are very thankful that the patient responded well to the surgery and has fully recovered."

Dr. Mariam Al Raeesi, CEO of Dubai Hospital, highlighted the collaborative efforts of the multidisciplinary team in deciding to proceed with the surgery. "After careful consideration and collaboration among our medical and surgical experts, it was agreed to undertake this complex procedure," Dr. Al Raeesi said. "The enormous success of the procedure is a huge testament to our medical staff here at Dubai Hospital, putting in practice our Patient First promise focused on delivering high-quality care for patients."

Dubai Hospital is one of the largest specialized tertiary hospitals in the UAE. As part of Dubai Health, the first integrated academic health system in Dubai, the hospital provides comprehensive services in all healthcare disciplines, relevant to the needs of the community.